4/28
02:06 am
ions
Ionis partner GSK announces bepirovirsen accepted for Priority Review and granted Breakthrough Therapy Designation by U.S. FDA as a potential first-in-class medicine for chronic hepatitis B
Low
Report
Ionis partner GSK announces bepirovirsen accepted for Priority Review and granted Breakthrough Therapy Designation by U.S. FDA as a potential first-in-class medicine for chronic hepatitis B
4/26
01:23 pm
ions
A Look At Ionis Pharmaceuticals (IONS) Valuation After Strong One Year Returns And Recent Pullback [Yahoo! Finance]
Low
Report
A Look At Ionis Pharmaceuticals (IONS) Valuation After Strong One Year Returns And Recent Pullback [Yahoo! Finance]
4/23
01:03 pm
ions
Ionis Pharmaceuticals (IONS) had its price target lowered by TD Cowen from $110.00 to $108.00. They now have a "buy" rating on the stock.
Low
Report
Ionis Pharmaceuticals (IONS) had its price target lowered by TD Cowen from $110.00 to $108.00. They now have a "buy" rating on the stock.
4/22
07:29 am
ions
Ionis Pharmaceuticals (IONS) was upgraded by Canaccord Genuity Group Inc. to "strong-buy".
Low
Report
Ionis Pharmaceuticals (IONS) was upgraded by Canaccord Genuity Group Inc. to "strong-buy".
4/21
11:46 am
ions
Ionis (IONS) Q4 2025 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]
Low
Report
Ionis (IONS) Q4 2025 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]
4/21
09:02 am
ions
Ionis Pharmaceuticals (IONS) had its "overweight" rating reaffirmed by Morgan Stanley.
Low
Report
Ionis Pharmaceuticals (IONS) had its "overweight" rating reaffirmed by Morgan Stanley.
4/21
07:00 am
ions
Ionis presents new data from pivotal study of zilganersen in Alexander disease (AxD) at AAN 2026 Annual Meeting
Low
Report
Ionis presents new data from pivotal study of zilganersen in Alexander disease (AxD) at AAN 2026 Annual Meeting
4/20
06:04 pm
ions
Ionis Pharmaceuticals (IONS) was given a new $110.00 price target by Canaccord Genuity Group Inc..
Low
Report
Ionis Pharmaceuticals (IONS) was given a new $110.00 price target by Canaccord Genuity Group Inc..
4/20
04:26 pm
ions
How The Ionis Pharmaceuticals (IONS) Story Is Shifting With New Targets And 2026 Catalysts [Yahoo! Finance]
Low
Report
How The Ionis Pharmaceuticals (IONS) Story Is Shifting With New Targets And 2026 Catalysts [Yahoo! Finance]
4/15
07:05 am
ions
Ionis to hold first quarter 2026 financial results webcast
Low
Report
Ionis to hold first quarter 2026 financial results webcast
4/10
12:05 pm
ions
Ionis Pharmaceuticals (IONS) was given a new $104.00 price target by Raymond James Financial, Inc..
Low
Report
Ionis Pharmaceuticals (IONS) was given a new $104.00 price target by Raymond James Financial, Inc..
4/9
12:18 pm
ions
Ionis Pharmaceuticals (IONS) had its price target raised by Bank of America Corporation from $100.00 to $111.00. They now have a "buy" rating on the stock.
Low
Report
Ionis Pharmaceuticals (IONS) had its price target raised by Bank of America Corporation from $100.00 to $111.00. They now have a "buy" rating on the stock.
4/6
08:02 am
ions
Rare Stock Picks In March 2026 - From 23 Discerning Analysts [Seeking Alpha]
Low
Report
Rare Stock Picks In March 2026 - From 23 Discerning Analysts [Seeking Alpha]
3/30
03:07 am
ions
EMA validates indication extension application for Tryngolza® (olezarsen) for the treatment of severe hypertriglyceridemia (sHTG) [Yahoo! Finance]
Low
Report
EMA validates indication extension application for Tryngolza® (olezarsen) for the treatment of severe hypertriglyceridemia (sHTG) [Yahoo! Finance]
3/28
10:27 am
ions
FDA Priority Review Puts Ionis Zilganersen At Center Of Rare-Disease Story [Yahoo! Finance]
Low
Report
FDA Priority Review Puts Ionis Zilganersen At Center Of Rare-Disease Story [Yahoo! Finance]
3/27
01:25 pm
ions
Why Is Ionis Pharmaceuticals (IONS) Down 7.9% Since Last Earnings Report? [Yahoo! Finance]
Neutral
Report
Why Is Ionis Pharmaceuticals (IONS) Down 7.9% Since Last Earnings Report? [Yahoo! Finance]
3/26
08:53 am
ions
Ionis Pharmaceuticals (IONS) had its price target raised by Barclays PLC from $95.00 to $106.00. They now have an "overweight" rating on the stock.
Medium
Report
Ionis Pharmaceuticals (IONS) had its price target raised by Barclays PLC from $95.00 to $106.00. They now have an "overweight" rating on the stock.
3/25
11:44 am
ions
Ionis Pharmaceuticals (IONS) had its price target raised by Needham & Company LLC from $103.00 to $105.00. They now have a "buy" rating on the stock.
Low
Report
Ionis Pharmaceuticals (IONS) had its price target raised by Needham & Company LLC from $103.00 to $105.00. They now have a "buy" rating on the stock.
3/25
10:57 am
ions
Ionis Pharmaceuticals (IONS) had its price target raised by HC Wainwright from $110.00 to $120.00. They now have a "buy" rating on the stock.
Low
Report
Ionis Pharmaceuticals (IONS) had its price target raised by HC Wainwright from $110.00 to $120.00. They now have a "buy" rating on the stock.
3/23
07:00 am
ions
Ionis announces zilganersen New Drug Application for Alexander disease (AxD) accepted by FDA for Priority Review
Low
Report
Ionis announces zilganersen New Drug Application for Alexander disease (AxD) accepted by FDA for Priority Review
3/22
05:29 am
ions
Ionis Board Shakeup And Valuation Gap Draw Investor Attention [Yahoo! Finance]
Low
Report
Ionis Board Shakeup And Valuation Gap Draw Investor Attention [Yahoo! Finance]
3/18
02:34 pm
ions
National Triglyceride Alliance Celebrates One Year of Impact and Recognizes National Triglycerides Day [Yahoo! Finance]
Low
Report
National Triglyceride Alliance Celebrates One Year of Impact and Recognizes National Triglycerides Day [Yahoo! Finance]
3/18
10:32 am
ions
Why Ionis Pharmaceuticals' (IONS) 2026 Catalyst Pipeline Supported Leerink's Higher Target [Yahoo! Finance]
Low
Report
Why Ionis Pharmaceuticals' (IONS) 2026 Catalyst Pipeline Supported Leerink's Higher Target [Yahoo! Finance]
3/9
06:11 pm
ions
Ionis Pharmaceuticals, Inc. (IONS) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]
Low
Report
Ionis Pharmaceuticals, Inc. (IONS) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]
3/9
07:00 am
ions
Ionis announces changes to Board of Directors
Low
Report
Ionis announces changes to Board of Directors